John R. Yarnold

Magnetic resonance imaging of induration in the irradiated breast.

Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial.

Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?

Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?

Characterization of target volume changes during breast radiotherapy using implanted fiducial markers and portal imaging.

Shorter fractionation schedules in breast cancer radiotherapy: clinical and economic implications.

Tumor bed delineation for partial breast and breast boost radiotherapy planned in the prone position: what does MRI add to X-ray CT localization of titanium clips placed in the excision cavity wall?

Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.

How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy?

Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches.

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

Hypofractionated radiotherapy for breast cancer.

Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.

Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry.

Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations.

A randomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion.

Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients.

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

Ductal carcinoma in situ of the breast.

Conducting radiogenomic research--do not forget careful consideration of the clinical data.

The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Changes in mast cell number and stem cell factor expression in human skin after radiotherapy for breast cancer.

Late effects of breast radiotherapy.

Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.